When was Exact Sciences founded?

Exact Sciences was founded in 1995 and raised its 1st funding round 14 years after it was founded.

Where is Exact Sciences located?

Exact Sciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin.

How many employees does Exact Sciences have?

As of Sep 30, 2026, the latest employee count at Exact Sciences is 4930.

Is Exact Sciences a funded company?

Exact Sciences is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Jun 12, 2009.

When was the latest funding round of Exact Sciences?

Exact Sciences' latest funding was a $***** Post IPO round on Mar 08, 2019, with participation from 0 investor.

What is the annual revenue of Exact Sciences?

Annual revenue of Exact Sciences is more than $1B as on Dec 31, 2025

Where does Exact Sciences rank among its competitors?

Exact Sciences ranks 1st amongst 133 active competitors, of which 45 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was GRAIL, which secured $110M in Jun, 2026.

Who are the top competitors of Exact Sciences?

Exact Sciences' top competitors include GRAIL, UDX and Volition. Among them, GRAIL secured the most recent funding round in June, 2026.

Exact Sciences - 2026 Company Profile, Funding, Competitors & Financials

Q: Is Exact Sciences an acquired company?

Exact Sciences got acquired by Abbott on Mar 20, 2026.

Exact Sciences is an acquired company based in Madison (United States), founded in 1995. It operates as a Provider of non-invasive molecular diagnostic testing solutions for cancer. Exact Sciences has raised an undisclosed amount in funding. The company has 133 active competitors, including 45 funded and 22 that have exited. Its top competitors include companies like GRAIL, UDX and Volition.

Company Details

Provider of non-invasive molecular diagnostic testing solutions for cancer. The company's product includes Cologuard is intended for the qualitative detection of colorectal neoplasia-associated DNA markers and for the presence of occult hemoglobin in human stool to estimate a patient's risk of developing colorectal cancer. Also, it offers an MCED blood test for multi-cancer detection.

Website: www.exactsciences.com/
Social
Registered Address: Madison, Wisconsin

Key Metrics

Founded Year

1995

Location

Madison, United States

Stage

Acquired

Latest Funding Round

Post IPO, Mar 08, 2019, $*****

Investors

Petrillo Capital & 9 more

Ranked

1^st among 133 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

4,930 as on Sep 30, 2026

Investment & Acquisitions

KeyCare & 14 more

Similar Companies

GRAIL & 186 more

Exit Details

Acquired by Abbott (Mar 20, 2026)

View Exact Sciences' full profile

Exact Sciences is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
EXACT SCIENCES CORP CIN: 1124140 , United States, Active	Feb 09, 1995	$1B+ (As on Dec 31, 2025)	6600 (As on Dec 31, 2023)	-
Exact Sciences Corporation CIN: 20478229 , United States, Active	Dec 26, 999	-	6706 (As on Dec 31, 2024)	-

Exact Sciences got acquired by Abbott on Mar 20, 2026 at an acquisition amount of $*****.

Click here to take a look at Exact Sciences's acquisition in detail

Exact Sciences has raised funding over 4 rounds. Its first funding round was on Jun 12, 2009. Exact Sciences has 10 institutional investors.

Here is the list of recent funding rounds of Exact Sciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 08, 2019	8400552	Post IPO	5151269	5984629	2620275	1062365
Jun 2018	4936725	Post IPO	6556139	7719446	5304638	8332493
Jan 2018	1528458	Post IPO	6711815	5724712	7537236	Bank of America

Access funding benchmarks and valuations. Sign up today!

View details of Exact Sciences's funding rounds and investors

Exact Sciences' employee count trend

Exact Sciences has 4,930 employees as of Sep 26. Here is Exact Sciences's employee count trend over the years:

Uncover Exact Sciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Exact Sciences include GRAIL, UDX and Volition. Here is the list of Top 10 competitors of Exact Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Exact Sciences 1995, Madison (United States), Acquired	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Back Bay Group & 8 others	67/100
2nd	GRAIL 2016, Menlo Park (United States), Public	Developer of a screening platform for circulating tumor DNA to detect cancer	$2B	Arch Venture Partners, PSP Investments & 52 others	69/100
3rd	UDX 2012, Seville (Spain), Series C	Developer of non-invasive blood-based diagnostics for cancer	$105M	Quest Diagnostics, Olympus & 6 others	67/100
4th	Volition 1995, Gembloux (Belgium), Public	Developer of cancer diagnostic tests	-	Namur Invest, Belgium & 1 others	61/100
5th	Biocartis 2007, Mechelen (Belgium), Public	Manufacturer of automated molecular diagnostic systems for oncology biomarker testing	$305M	Johnson & Johnson Innovation – JJDC, Advent Life Sciences ... & 18 others	58/100
6th	Biovica 2009, Uppsala (Sweden), Public	Drug response monitoring assay	$4.27M	EIC Fund, Europa	56/100
7th	Tethis 2004, Milan (Italy), Series A	Provider of automated solutions for in liquid biopsy	$15.3M	sanpaolope.com, Indaco Venture Partners & 5 others	55/100
8th	Mursla 2017, London (United Kingdom), Seed	Provider of diagnostic device for cancer detection	$547K	Future Fund, TA Ventures & 26 others	55/100
9th	Valirx 2000, London (United Kingdom), Public	Developer of novel technologies and products in oncology therapeutics and diagnostics	-	-	53/100
10th	Predilife 2004, Villejuif (France), Public	Provider of personalized breast screening	-	-	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Exact Sciences's competitors? Click here to see the top ones

Exact Sciences has made 2 investments in companies including KeyCare and Thrive Earlier Detection. Exact Sciences has also acquired 13 companies including Resolution Bioscience and OmicEra Diagnostics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 03, 2026	Investments	KeyCare	2020	Chicago (United States)
Sep 12, 2023	Acquisition	Resolution Bioscience	2012	Kirkland (United States)
May 10, 2022	Acquisition	OmicEra Diagnostics	2019	Munich (Germany)